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A R T I C L E   I N F O S U M M A R Y 
Cancer has always been a big concern for human health. There is always an 
increased need for fabrication of newer drugs or repurposing existing drugs to treat 
cancer. Apart from being an antipsychotic agent, pimozide has already shown its 
anticancer activity against various cancers in several studies. The aim of the present 
study was to fabricate pimozide loaded PLGA nanoparticles and characterise them. 
Single emulsion and microfluidic techniques were used to prepare nanoparticles. 
Physicochemical properties such as particle size, shape, surface charge and 
encapsulation efficiency were investigated. Results showed that the nanoparticles 
had an average size distribution of 200-300 nm, were spherical in shape and 
negatively charged. Additionally, a high encapsulation efficiency (50-89%) makes 
these nanoparticles potential drug delivery systems to target cancer cells. 
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INTRODUCTION 
According to WHO, cancer is the second leading cause 
of death worldwide reporting 8.8 million deaths in 
2015, accounting for approximately 1 in 6 deaths 
(World Cancer Report, 2014). Although many 
treatment options exist, there is always an increased 
need for fabrication of newer drugs or repurposing 
existing drugs. Pimozide is an antipsychotic drug 
indicated for Tourette Syndrome and schizophrenia. 
However, several studies have found significant 
anticancer activity with pimozide. It inhibits the 
growth of breast cancer cells, prostate cancer cells and 
glioblastoma cells (Lee et al., 2016). The delivery of 
pimozide to the targeted cancer cells is challenging 
because only 40-50% pimozide (oral administration) is 
bioavailable after first-pass metabolism in the liver. 
Moreover, overdose of pimozide causes severe 
extrapyramidal symptoms, hypotension, sedation, QT 
interval prolongation and ventricular arrhythmias 
(Fako et al., 2016). To solve this problem, 
biodegradable nanoparticles could be employed as 
pimozide delivery systems which might provide 
enhanced biocompatibility, less or no systemic 
toxicity, increased encapsulation efficiency, and very 
convenient release profile. Poly-D-L-lactic-co-glycolic 
acid (PLGA) is one of the most extensively used, US 
FDA and European Medicine Agency (EMA) 
approved biodegradable polymers for therapeutic use 
in humans as many anticancer drugs including 
paclitaxel and doxorubicin have been successfully 
loaded in PLGA nanoparticles (Danhier et al., 2012). 
We prepared pimozide loaded PLGA nanoparticles by 
using two techniques. This work aimed to investigate 
the physicochemical properties of the prepared 
nanoparticles. 
MATERIALS AND METHODS 
Pimozide, both ester terminated PLGA (Resomer® RG 
503, MW 24 kDa-38 kDa) and acid terminated PLGA 
(MW 30 kDa-60 kDa) having 50:50 lactic: glycolic ratio, 
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dichloromethane (Chromasolv®, ≥99.8%) which was 
analytical grade and poly (vinyl alcohol) (PVA, 87-89% 
hydrolysed, MW 31 kDa-50 kDa) were purchased from 
Sigma Aldrich company. Polysorbate 80 
(polyoxyethylene sorbitan monooleate/ TWEEN® 80, 
product of Switzerland) was purchased from Fluka 
Analytical. Acetonitrile (Pierce®, LC-MS grade) and 
ethanol (HPLC grade) were purchased from Thermo 
Fisher Scientific. Single emulsion-solvent evaporation 
and microfluidic techniques have been used to prepare 
nanoparticles. Pimozide encapsulation efficiency (EE) 
was analysed by a reverse-phase high performance 
liquid chromatography (RP-HPLC) method. Fourier 
Transform Infrared Spectroscopy (FTIR) confirmed the 
degree of interaction between drug and polymer. 
Particle size and zeta potential were measured by 
dynamic light scattering (DLS) technique. The surface 
morphology was studied by scanning electron 
microscopy (SEM). 
RESULTS AND DISCUSSION 
Results obtained (Table 1) show that nanoparticle size 
distribution was in the range of 200-300 nm regardless 
of the PLGA types and preparation techniques. 
Table 1. Physicochemical properties of prepared nanoparticles 







AF1.SE  236.3±51 0.221±0.14 -4.34±2.7 89 
AF2.SE 227.4±17 0.199±0.08 -5.53±0.9 83 
EF1.SE 262.1±10 0.328±0.05 -5.15±2.3 70 
EF2.SE 234.2±68 0.324±0.07 -8.66±1.3 76 
AF1.MF 224.9±13 0.172±0.05 -25.1±1.1 79 
AF2.MF 225.9±20 0.136±0.04 -22.2±1.7 108 
EF1.MF 229.2±58 0.201±0.13 -25.4±2.6 50 
EF2.MF 202.1±22 0.095±0.01 -21.5±1.6 83 
 
The microfluidic technique produced nanoparticles 
having a narrower polydispersity index (≈0.2) and 
higher negative zeta potential (-20 to -25 mV) than 
those from the single emulsion technique. This can be 
explained by the surface properties of PLGA/PVA 
nanoparticles (single emulsion) and PLGA/Tween® 
80 nanoparticles (microfluidic). 
 
 
Fig. 1. Scanning electron microscopy (SEM) image of 
prepared nanoparticles 
A high pimozide encapsulation efficiency (50-89%) 
was observed by both techniques, thus, making 
current formulations a potential therapeutic option to 
work on for cancer treatment. 
CONCLUSIONS 
For the first time, pimozide loaded PLGA 
nanoparticles were successfully prepared and 
characterised. Optimising the EE, size, and charge, 
while preserving stability and biological activity 
during fabrication can be achieved through 
adjustment of process variables. Future works on drug 
release, addition of surfactants and targeting ligands 
on nanoparticles, and in vitro studies on cancer cell 
lines will determine the superior formulation. 
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